Anthony M Villano

6PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Rheumatology and arthritisRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 17, 2026
Predicting Treatment Responses After Total Neoadjuvant Therapy for Rectal Cancer: Improving an Imperfect Process.

|Jun 25, 2025
Molecular Biomarkers for the Diagnosis and Prognostication of Pancreatic Ductal Adenocarcinoma.

James Sun, Morcos A Awad, Jennifer Hwang

|Nov 09, 2023
PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis.

Jia Hu, Meera R Hameed, Narasimhan P Agaram

|Apr 27, 2022
Total neoadjuvant therapy is associated with improved overall survival and pathologic response in pancreatic adenocarcinoma.

Anthony M Villano, Eileen O'Halloran, Neha Goel

|Oct 17, 2021
ASO Author Reflections: Retroperitoneal Soft Tissue Sarcoma: A Call for Collaboration and Scientific Inquiry.

Anthony M Villano, Jeffrey M Farma

|Oct 12, 2021
National Trends in Treatment for Retroperitoneal Soft Tissue Sarcoma: A Modern Appraisal of Variability in Therapeutic Strategies.

Anthony M Villano, Roberto J Vidri, Elaine T Vo

Pageof 1

Frequent Collaborators

1 joint publications

Sanjay S Reddy

1 joint publications

Jia Hu

1 joint publications

Meera R Hameed

1 joint publications

Narasimhan P Agaram